Close Menu

NEW YORK (GenomeWeb) – Qiagen and NeoGenomics said on Friday that they have inked a master service agreement designed to expedite the development and launch of companion diagnostics with pharmaceutical partners.

Under the terms of the partnership, Qiagen will provide investigational-use-only tests to NeoGenomics and other labs "enabling them to verify, set up, and run our companion diagnostics in clinical trials and in anticipation of regulatory approval," Qiagen CEO Peer Schatz said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.